Stacie Quedenfeld, APRN

Stacie Quedenfeld practices at Primary Care of Central Florida Inc in Orlando, Florida.

Stacie Quedenfeld's NPI, 1407410970, was assigned on April 30, 2019. Stacie Quedenfeld holds Florida license APRN11002198.

Stacie Quedenfeld's primary practice is Primary Care of Central Florida Inc, at 12301 Lake Underhill Rd, Orlando, FL 32828 in Orange County. The practice phone is (321) 235-0692.

Stacie Quedenfeld's primary practice is Primary Care of Central Florida Inc in Orlando, Florida. The medical group on file is Primary Care of Central Florida. Dmand AI also links Stacie Quedenfeld to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stacie Quedenfeld practices. Vendor and product names are available with a free account.

Family is Stacie Quedenfeld's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Stacie Quedenfeld is licensed in Florida.

Dmand AI lists anxiety, arthritis, benign or precancerous skin growths, bladder disease, chronic diabetes, chronic kidney disease, chronic lung disease and chronic obstructive pulmonary disease (COPD) among the conditions Stacie Quedenfeld treats.

CMS counts 22 Medicare patients who saw Stacie Quedenfeld in 2024. The largest group is 85 and over, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stacie Quedenfeld's median patient age at 75, with 50% women.

In 2024, Stacie Quedenfeld wrote 423 Medicare Part D claims for 65 patients. 83% of them were for generic drugs. CMS names the drug for 186 of them, across 11 drugs with 11 or more claims each, at $13,931 in total drug cost.

Stacie Quedenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stacie Quedenfeld as offering telehealth.

CMS Open Payments shows 8 general payments to Stacie Quedenfeld from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $122.